The guidelines included on this page have been commissioned and endorsed by the BSPED and reflect the Society's views on best practice for the majority of patients with that condition. However, each patient should be considered as an individual in the context of their condition and other medication and therefore the readers' discretion is required in the application of their use. Every effort has been made to ensure the factual accuracy of the contents but no liability can be accepted for any litigation, claims or complaints arising from the use of the guidelines.
These guidelines are produced by accredited national bodies (e.g. NICE, RCPCH, ACDC, SIGN), of which BSPED are stakeholders. BSPED may have been involved in the development of these guidelines but are not the original authors of these guidelines.
Please review the BSPED Clinical Guideline Endorsement document for the process. Authors of guidelines are required to sign the BSPED Declaration of Interest form (definitions of conflicting interests are listed on the form).
BSPED Position Statement 2017 on weight limits and the DKA Calculator: Disclaimer
The DKA Calculator 2015 does not yet have official approval by the MHRA as a medical device. Pending formal MHRA approval, clinicians need to be aware that they use this calculator at their own risk and that they are aware that DKA calculator does not have a weight limit. Adjustment to 50th centile weight for age or inserting a weight limit of 70 kg should be considered in obese type 1 children presenting with DKA
These guidelines are local trust endocrine guidelines which have been made available to BSPED members. The BSPED have not been involved in the development of these guidelines and take no responsibility for the content. Please note local guidelines may vary between Trusts.
If a local trust wishes to publish their guidelines on the BSPED website, please email the BSPED Office (email@example.com) and we will put you in touch with our Clinical Guideline Officer, Dr May Ng.